Overcoming prostate cancer drug resistance with a novel organosilicon small molecule
A major challenge to the treatment of advanced prostate cancer (PCa) is the development of resistance to androgen-deprivation therapy (ADT) and chemotherapy. It is imperative to discover effective therapies to overcome drug resistance and improve clinical outcomes. We have developed a novel class of...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1f6b060eb516456db0aa542c6160f224 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|